These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23587916)

  • 1. Allele frequency distribution of CYP2C9 2 and CYP2C9 3 polymorphisms in six Mexican populations.
    Castelán-Martínez OD; Hoyo-Vadillo C; Sandoval-García E; Sandoval-Ramírez L; González-Ibarra M; Solano-Solano G; Gómez-Díaz RA; Parra EJ; Cruz M; Valladares-Salgado A
    Gene; 2013 Jul; 523(2):167-72. PubMed ID: 23587916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variation among four Mexican populations (Huichol, Purepecha, Tarahumara, and Mestizo) revealed by two VNTRs and four STRs.
    Rangel-Villalobos H; Rivas F; Sandoval L; Ibarra B; Garcìa-Carvajal ZY; Cantú JM; Figuera LE
    Hum Biol; 2000 Dec; 72(6):983-95. PubMed ID: 11236868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP2C9 allele frequency differences between populations of Mexican-Mestizo, Mexican-Tepehuano, and Spaniards.
    Dorado P; Sosa-Macias MG; Peñas-Lledó EM; Alanis-Bañuelos RE; Wong ML; Licinio J; Lares-Asseff I; Llerena A
    Pharmacogenomics J; 2011 Apr; 11(2):108-12. PubMed ID: 20458343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of three SNPs related to low bone mineral density in Amerindian groups and Mestizos from Mexico.
    Nuño-Arana I; Sahagún-Núñez Vdel R; Muñoz-Valle JF; Sandoval L; Pinto-Escalante D; Páez-Riberos LA; Lazalde B; Maldonado-González M; Rangel-Villalobos H
    Am J Hum Biol; 2012; 24(4):569-72. PubMed ID: 22434650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of admixture components on CYP2C9*2 allele frequency in eight indigenous populations from Northwest Mexico.
    Sosa-Macías M; Lazalde-Ramos BP; Galaviz-Hernández C; Rangel-Villalobos H; Salazar-Flores J; Martínez-Sevilla VM; Martínez-Fierro ML; Dorado P; Wong ML; Licinio J; LLerena A
    Pharmacogenomics J; 2013 Dec; 13(6):567-72. PubMed ID: 23358499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP2C9 and CYP2C19 Allele and Haplotype Distributions in Four Mestizo Populations from Western Mexico: An Interethnic Comparative Study.
    Saldaña-Cruz AM; León-Moreno LC; Sánchez-Corona J; Santiago DA; Mendoza-Carrera F; Castro-Martínez XH; García-Zapién AG; Morán-Moguel MC; Flores-Martínez SE
    Genet Test Mol Biomarkers; 2016 Nov; 20(11):702-709. PubMed ID: 27617498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variation of the FMR1 gene among four Mexican populations: Mestizo, Huichol, Purepecha, and Tarahumara.
    Barros-Núñez P; Rosales-Reynoso MA; Sandoval L; Romero-Espinoza P; Troyo-Sanromán R; Ibarra B
    Am J Hum Biol; 2008; 20(3):259-63. PubMed ID: 18172867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interethnic differences of CYP2C9 alleles in healthy Hungarian and Roma population samples: relationship to worldwide allelic frequencies.
    Sipeky C; Lakner L; Szabo M; Takacs I; Tamasi V; Polgar N; Falus A; Melegh B
    Blood Cells Mol Dis; 2009; 43(3):239-42. PubMed ID: 19541511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variability among Mexican Mestizo and Amerindian populations based on three ABCB1 polymorphisms.
    Favela-Mendoza AF; Rangel-Villalobos H; Fricke-Galindo I; Ortega-Vázquez A; Martínez-Cortés G; López-López M
    Mol Biol Rep; 2018 Dec; 45(6):2525-2533. PubMed ID: 30317428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allele and genotype frequencies of CYP2C9 within an Iranian population (Mazandaran).
    Hashemi-Soteh SM; Shahabi-Majd N; Gholizadeh AR; Shiran MR
    Genet Test Mol Biomarkers; 2012 Jul; 16(7):817-21. PubMed ID: 22288731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytochrome P4501A1 polymorphisms in the Amerindian and Mestizo populations of Mexico.
    Fragoso JM; Juárez-Cedillo T; Hernández-Pacheco G; Ramírez E; Zuñiga J; Izaguirre R; de la Peña A; Granados J; Vargas-Alarcón G
    Cell Biochem Funct; 2005; 23(3):189-93. PubMed ID: 15376230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of mtDNA haplogroups in 14 Mexican indigenous populations.
    Peñaloza-Espinosa RI; Arenas-Aranda D; Cerda-Flores RM; Buentello-Malo L; González-Valencia G; Torres J; Alvarez B; Mendoza I; Flores M; Sandoval L; Loeza F; Ramos I; Muñoz L; Salamanca F
    Hum Biol; 2007 Jun; 79(3):313-20. PubMed ID: 18078204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of CYP2C9 polymorphisms in the south of Europe.
    Sánchez-Diz P; Estany-Gestal A; Aguirre C; Blanco A; Carracedo A; Ibáñez L; Passiu M; Provezza L; Ramos-Ruiz R; Ruiz B; Salado-Valdivieso I; Velasco EA; Figueiras A
    Pharmacogenomics J; 2009 Oct; 9(5):306-10. PubMed ID: 19381164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the most common CYP2C9 and CYP2C19 allelic variants in the population from the Republic of Macedonia.
    Jakovski K; Nestorovska AK; Labacevski N; Dimovski AJ
    Pharmazie; 2013 Nov; 68(11):893-8. PubMed ID: 24380239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotype frequencies of VKORC1 and CYP2C9 in native and Mestizo populations from Mexico, potential impact for coumarin dosing.
    Villegas-Torres B; Sánchez-Girón F; Jaramillo-Villafuerte K; Soberón X; Gonzalez-Covarrubias V
    Gene; 2015 Mar; 558(2):235-40. PubMed ID: 25560189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of the Val108/158Met polymorphism of the COMT gene in healthy Mexican population.
    González-Castro TB; Tovilla-Zárate C; Juárez-Rojop I; Pool García S; Genis A; Nicolini H; López Narváez L
    Gene; 2013 Sep; 526(2):454-8. PubMed ID: 23774690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta1 adrenergic receptor polymorphisms Arg389Gly and Ser49Gly in the Amerindian and Mestizo populations of Mexico.
    Fragoso JM; Rodríguez-Pérez JM; Pérez-Vielma N; Martínez-Rodríguez N; Vargas-Alarcón G
    Hum Biol; 2005 Aug; 77(4):515-20. PubMed ID: 16485781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphisms of CYP2C9 and CYP2C19 are not related to drug-induced idiosyncratic liver injury (DILI).
    Pachkoria K; Lucena MI; Ruiz-Cabello F; Crespo E; Cabello MR; Andrade RJ;
    Br J Pharmacol; 2007 Mar; 150(6):808-15. PubMed ID: 17279092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower frequency of CYP2C9*2 in Mexican-Americans compared to Spaniards.
    LLerena A; Dorado P; O'Kirwan F; Jepson R; Licinio J; Wong ML
    Pharmacogenomics J; 2004; 4(6):403-6. PubMed ID: 15452553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of CYP2D6 and CYP2C19 polymorphisms associated with poor metabolizer phenotype in five Amerindian groups and western Mestizos from Mexico.
    Salazar-Flores J; Torres-Reyes LA; Martínez-Cortés G; Rubi-Castellanos R; Sosa-Macías M; Muñoz-Valle JF; González-González C; Ramírez A; Román R; Méndez JL; Barrera A; Torres A; Medina R; Rangel-Villalobos H
    Genet Test Mol Biomarkers; 2012 Sep; 16(9):1098-104. PubMed ID: 22913530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.